[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2015/210690,2015,A1Locationinpatent:Paragraph0231;0859;0860
[2]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2015/116786,2015,A1Locationinpatent:Page/Pagecolumn229
1380571-72-1
1359655-43-8
1523530-72-4
1803592-63-3
1864072-41-2
938063-63-9 | Methyl 3-((2,2-dimethylbutanoyl)thio)propanoate | AA00IHS6 | MFCD22200648
943519-37-7 | Methyl 2,4-dihydroxy-5-isopropylbenzoate | AA00II09 | MFCD16037579
944899-27-8 | 6-Fluorochroman-3-carboxylic acid | AA00II5P | MFCD10696110
946761-08-6 | (4-Boc-amino-tetrahydrothiopyran-4-yl)-acetic acid | AA00IID8 | MFCD09264197
94856-25-4 | Aberchrome 670 | AA00IIIM | MFCD07368579
951317-39-8 | 3-Fluoro-4-isopropoxynitrobenzene | AA00IIOQ | MFCD12547858
952664-69-6 | 2-Bromo-5-fluoro-4-nitroaniline | AA00IITV | MFCD22381005
955082-95-8 | Trans-3-fluoropiperidin-4-ol | AA00IJ3A | MFCD28014013
956786-53-1 | 1-(3,4-dimethoxybenzyl)-3,5-dimethyl-1H-pyrazol-4-amine | AA00IJ9G | MFCD04969983
958030-46-1 | 2-formyl-3-methoxyphenylboronic acid | AA00IJDN | MFCD10566986
956374-40-6
1797015-21-4
1290035-23-2
164929-15-1